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Abstract Worldwide, perinatal asphyxia is an important
cause of morbidity and mortality among term-bornchildren.
Overactivation of the N-methyl-D-aspartate receptor
(NMDAr)playsacentralroleinthepathogenesisofcerebral
hypoxia–ischemia, but the role of both endogenous NMDAr
co-agonists D-serine and glycine remains largely elusive.
We investigated D-serine and glycine concentration changes
in rat glioma cells, subjected to oxygen and glucose depri-
vation (OGD) and CSF from piglets exposed to hypoxia–
ischemia by occlusion of both carotid arteries and hypoxia.
We illustrated these ﬁndings with analyses of cerebrospinal
ﬂuid (CSF) from human newborns affected by perinatal
asphyxia. Extracellular concentrations of glycine and
D-serine were markedly increased in rat glioma cells
exposed to OGD, presumably through increased synthesis
from L-serine. Upon reperfusion glycine concentrations
normalized and D-serine concentrations were signiﬁcantly
lowered. The in vivo studies corroborated the ﬁnding of
initially elevated and then normalizing concentrations of
glycine and decreased D-serine concentrations upon reper-
fusion These signiﬁcant increases of both endogenous
NMDAr co-agonists in combination with elevated gluta-
mate concentrations, as induced by global cerebral ische-
mia, are bound to lead to massive NMDAr activation,
excitotoxicity and neuronal damage. Inﬂuencing these
NMDAr co-agonist concentrations provides an interesting
treatment target for this common, devastating and currently
poorly treatable condition.
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Introduction
Perinatal asphyxia is the consequence of impaired blood
supply between mother and fetus, leading to insufﬁcient
delivery of oxygen, glucose and other blood-borne fuels to
fetal organs, including the brain. The short-term clinical
consequences include persistent low Apgar scores, multi-
organ failure and neurological sequelae. In the long-term,
this might result in cerebral palsy, mental retardation,
visual and acoustic impairment and epilepsy (Robertson
et al. 1989; Shankaran et al. 1991). In spite of improve-
ments in perinatal care, the incidence and outcome of
perinatal asphyxia remain relatively unchanged. Of the
yearly estimated 4 million neonatal deaths worldwide,
approximately 1 million is caused by perinatal asphyxia
(Lawn et al. 2005). Of infants with moderate encephalop-
athy, 10% die, and 30% of those who survive, have dis-
abilities. Among infants with severe encephalopathy, 60%
die, and many, if not all survivors are handicapped
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Amino Acids (2012) 43:355–363
DOI 10.1007/s00726-011-1086-9(Robertson et al. 1989; Shankaran et al. 1991). Treatment
is currently aimed at supportive intensive care, recently
combined with hypothermia (Selway 2010).
It has been ﬁrmly established that excessive excitation
of the N-methyl-D-aspartate receptor (NMDAr) plays a
central role in the pathogenesis of hypoxic-ischemic dam-
age, especially in the developing brain (Sattler and Tymi-
anski 2001). The NMDAr requires simultaneous binding by
glutamate and a co-agonist for activation. It had long been
assumed that glycine was the endogenous co-agonist.
However, recent studies have shown that D-serine is the
main endogenous co-agonist for most NMDAr subtypes in
most brain areas (Mothet et al. 2000). Since NMDArs
appear not to be saturated during physiological conditions
(Bergeron et al. 1998), elevations in glycine or D-serine
concentrations may lead to increased toxicity during
pathological conditions, such as hypoxia–ischemia.
NMDAr activation and D-serine concentrations are strongly
developmentally regulated (Fuchs et al. 2006), implying a
speciﬁc role in central nervous system (CNS) development.
Alterations in D-serine concentrations and NMDAr acti-
vation during this intense period of embryonic and early
postnatal CNS development, induced for instance by
perinatal asphyxia, may therefore be particularly deleteri-
ous. The synthesizing (Wolosker et al. 1999) and metab-
olizing (Molla et al. 2006) enzymes of D-serine and glycine
have been characterized (Fig. 1). By pharmacological
manipulation, this might yield new potential candidates for
pharmacological intervention after perinatal asphyxia.
Despite this exciting hypothesis, most research has
focused on glutamate, and the contribution of D-serine and
glycine to the pathogenesis of perinatal asphyxia remains
largely elusive. Therefore, we investigated D-serine and
glycine concentration changes in different models for
global ischemia.
Cell cultures
We subjected rat glioma cells to oxygen–glucose depriva-
tion (OGD), a commonly used in vitro model for global
ischemia, although the duration and depth of oxygen and
glucose deprivation vary between studies (Jones et al.
2004). Although neurons are far more susceptible to
ischemic brain damage than neighboring astrocytes, glioma
cells were studied, because of emerging evidence that
astrocytes contribute substantially to neuronal fate in
cerebral hypoxia–ischemia (Rossi et al. 2007). By studying
astrocytes in isolation, the direct effects of OGD on
astrocytes could be visualized without the effects of
stressed neuronal cells complicating interpretation.
Piglets
Analysis of CSF from piglets exposed to hypoxia–ischemia
by occlusion of both common carotid arteries, combined
with hypoxia. Piglet brains correspond well with those of
term-born neonates (Dobbing and Sands 1979), and this
animal model is commonly used to study global ischemia
(Fritz et al. 1999; Peeters-Scholte et al. 2002).
We illustrated these ﬁndings with cerebrospinal ﬂuid
(CSF) analyses from a small number of newborns with and
without perinatal asphyxia. Despite being a global marker
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123for concentration differences in brain regions, CSF is
the most accessible CNS marker in these critically ill
newborns.
In all models, we found consistent time-dependent
changes in D-serine and glycine concentrations upon
hypoxia–ischemia and reperfusion. Together with the
known increases in extracellular glutamate concentrations
(Benveniste et al. 1984; Gucuyener et al. 1999; Puka-
Sundvall et al. 1996; Ueda et al. 1992) after hypoxia–
ischemia, the increased concentrations of both NMDAr co-
agonists ought to lead to massive NMDAr activation,
resulting in excitotoxicity and neuronal damage.
Materials and methods
Cell cultures
Materials
Rat glioma C6 cells were cultured in F-12 Kaighn’s med-
ium supplemented with 10% fetal calf serum and 100 lg/ml
penicillin/streptomycin (all from Gibco Life Technologies,
Invitrogen, Breda, The Netherlands). To create normogly-
cemic and hypoglycemic conditions, media identical in
inorganic salt, amino acid and vitamin composition and
only different in glucose content (RPMI 1640 BE-12 702F:
2,000 mg/l and BE-12 752F: 0 mg/l, Bio Whittaker, Breda,
The Netherlands), supplemented with 10% fetal calf serum
and 100 lg/ml penicillin/streptomycin (Gibco Life Tech-
nologies, Invitrogen, Breda, The Netherlands) were used.
Hypoxia was applied by culturing samples in an in VIVO2
Hypoxia workstation 1000 (Biotrace International, Mid
Glamorgan, UK), equipped with a Ruskinn gas mixer
module V2 (Biotrace International, Mid Glamorgan, UK).
Oxygen level was set at 1%, CO2 at 5% and H2 at 0%.
Experimental design
The experiment was started by washing 6 9 6 well plates
(C2–C3 and S2–S3 started on day 1; C1 and S1 started
24 h (h) later, Fig. 2) of near conﬂuent glioma C6 cells
twice with phosphate buffered saline and applying the
experimental conditions (6 different samples per condi-
tion). A sample of the external medium was collected at the
end of each condition and stored at -20C until analysis.
This experiment (6 conditions; n = 6 for each condition)
was repeated on four different occasions.
Quantitative amino acid determination
D-Serine, L-serine and glycine concentrations were mea-
sured by stable isotope dilution gas and liquid
chromatographic–mass spectrometric methods as described
before (Fuchs et al. 2008).
Piglets
Seven newborn Dutch store piglets with a postnatal age
range from 1 to 3 days were exposed to hypoxia–ischemia
by occlusion of both common carotid arteries and reduction
of the fraction of inspired oxygen for 1 h as described
previously (Peeters-Scholte et al. 2002). CSF was with-
drawn at 3 h (n = 2) or 24 h (n = 5) after the start of
hypoxia–ischemia. CSF was also withdrawn in three con-
trol piglets, which underwent the same surgical procedure
but were not exposed to hypoxia–ischemia. Experimental
protocols were approved by the Animal Research Com-
mittee of the Utrecht University, The Netherlands.
Statistical analyses
Amino acid concentration differences between the external
medium of glioma C6 cells and ‘‘fresh medium’’ (from the
bottle, supplemented with fetal calf serum and penicillin/
streptomycin) were compared between experimental and
control conditions using the unpaired Student’s t test.
Similarly, amino acid concentrations in CSF from piglets
24 h after hypoxia–ischemia were compared with control
CSF, using the unpaired Student’s t test. The level of sig-
niﬁcance was set at p\0.05. Since there was CSF of only
two piglets 3 h after hypoxia–ischemia, these were not
included in the statistical analyses but presented to show
the trend of concentration changes.
C1
C2
T=24 hours T=48 hours T=0 hours
C3
S1
T=2 hours T=26 hours T=50 hours
S2
S3
Fig. 2 Experimental design of the Glioma C6 studies. Straight line
with arrows indicate normoxia and normoglycemia (21% O2; RPMI
12-702 medium). Dotted line with arrows oxygen and glucose
deprivation (1% O2; RPMI 12-752 medium) C1–C3 control 1–3;
S1–S3 sample 1–3
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123Results
Rat glioma C6 cells were incubated according to our
experimental protocol (see ‘‘Materials and methods’’). In
control conditions, D-serine concentrations in external
medium increased after 24 h to ?0.42 lM (Fig. 3) and
after 48 h to ?0.64 lM( p\0.05 when comparing 24 h
with 48 h), potentially through the release from vesicular
storage (Hur et al. 2010; Martineau et al. 2008; Mothet
et al. 2005). Glycine and L-serine concentrations decreased
during 24–48 h of normal conditions, suggesting uptake by
glioma cells.
Application of OGD for 24 or 48 h resulted in increases
in D-serine concentrations from ?0.42 lM (control condi-
tion) to ?0.69 lM at 24 h and from ?0.64 lM (control
condition) to ?0.91 lMa t4 8h( p\0.05 in both cases).
After OGD, glycine concentrations increased from -78 lM
(control condition) to ?109 lM at 24 h and from -151 lM
(control condition) to ?175 lMa t4 8h( p  0.01 in both
cases; p\0.05 when comparing 24–48 h OGD).
Interestingly, when simulating reperfusion by applying
normoxia/normoglycemia (NO/NG) after 24-h OGD,
D-serine concentrations were signiﬁcantly lowered when
compared to control conditions [?0.66 lM (control
condition) vs. ?0.34 lM (24 h OGD ? 24 h NO/NG),
p\0.01]. Concentrations of glycine normalized, by
decreasing to a lesser extent than during control condi-
tions [-116 lM (control condition) vs. -52 lM (24 h
OGD ? 24 h NO/NG)].
Concentrations of L-serine, the common precursor of
D-serine and glycine, and other amino acids (including
aspartate, another excitatory amino acid, data not shown)
decreased after OGD and in the reperfusion experiment,
but lesser than during control conditions, suggesting that
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Fig. 3 Medium concentration differences of the NMDAr agonists
D-serine, glycine and their common precursor L-serine after oxygen
and glucose deprivation (OGD) The ﬁgures represent the mean ±
standard deviation of the concentration differences of D-serine (a),
glycine (b) and L-serine (c) between fresh medium (directly taken
from the bottle, supplemented with fetal calf serum and penicillin/
streptomycin, as was used in the experiments) and the external
medium after 24 h OGD, 48 h OGD, and 24 h OGD followed by 24 h
normoxia/normoglycemia (NO/NG). These graphs represent the mean
of six different samples and six different controls during four different
experiments. *Signiﬁcant change with a p value\0.05 and
**0.05\p\0.1
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123the rise in D-serine and glycine is caused by speciﬁc syn-
thesis and not mere efﬂux due to, for instance, increased
cell wall permeability.
In order to gain insight into the mechanism responsible
for the changes in D-serine and glycine concentrations, a
ﬁfth condition was added (similar to S1 and C1, Fig. 2)b y
addition of 3 mg of the labeled stable isotope
13C3
15N
L-serine (Cambridge Isotope Laboratories, Inc., Andover,
USA) to 100 ml medium (to a concentration of 285 lM),
to which NO/NG, OGD, normoxia/hypoglycemia and
hypoxia/normoglycemia was applied during 48 h, because
the effects were most evident after 48 h (Fig. 3). By
labeling L-serine, the common endogenous precursor of
D-serine and glycine, we investigated D-serine and glycine
synthesis from L-serine by quantifying the resulting labeled
D-serine and glycine (Table 1). In this experiment, D-serine
concentrations remained unaffected by 48 h OGD when
compared to NO/NG (0.04 lM and 0.03 lM, respectively,
non-signiﬁcant), but these concentrations were very low,
nearing the limit of detection of the analytical method.
Glycine concentrations increased signiﬁcantly and mark-
edly after 48 h OGD (57.0 lM), when compared to control
conditions (34.3 lM, p\0.01). Synthesis of labeled gly-
cine after 48 h of control conditions is interesting when
considering the decrease in total glycine concentrations in
medium after 48 h (Fig. 3), implying simultaneous syn-
thesis and use of glycine under normal conditions. Under
NO/NG conditions, D-serine synthesis accounted for 0.02%
and glycine synthesis for 18% of L-serine use. D-Serine
synthesis from L-serine was not signiﬁcantly increased by
hypoxia, hypoglycemia or the combination (0.05\p\0.1
for OGD), but again, concentrations of labeled D-serine
were very low for quantiﬁcation with our analytical method.
Glycine synthesis from L-serine almost doubled to 28%
(p\0.01) upon hypoxia, decreased to 4.6% (p\0.01)
upon hypoglycemia and almost tripled to 51.5% (p\0.01)
upon OGD.
Piglets
Three hours after starting hypoxia–ischemia, piglets
showed an almost eightfold increase in glycine concen-
trations in CSF when compared to control piglets (Fig. 4).
Glycine concentrations remained markedly increased
(fourfold p\0.05) in CSF 24 h after starting hypoxia–
ischemia when compared to control piglets, but lesser than
3 h after hypoxia–ischemia (twofold reduction). D-Serine
concentrations seemed to rise marginally 3 h after
hypoxia–ischemia (but n = 2), and were signiﬁcantly
reduced at 24 h when compared with control piglets (40%
reduction, p\0.05). L-Serine concentrations appeared to
increase in CSF 3 h after hypoxia–ischemia (50%, but
again n = 2) and were similar to control values 24 h after
hypoxia–ischemia.
Discussion
Since perinatal asphyxia is an important contributor to
neonatal mortality and morbidity with poor curative treat-
ment options, this study was aimed to elucidate mecha-
nisms of NMDAr-associated excitotoxicity in hypoxia–
ischemia in an attempt to yield novel treatment strategies.
The necessity for NMDArs to be activated not only by
glutamate, but also by glycine or D-serine may be regarded
as a safety mechanism to prevent excitotoxicity. Our results
imply that this safety mechanism fails in global cerebral
ischemia, since we found that concentrations of both gly-
cine and D-serine signiﬁcantly increased during hypoxic-
ischemic conditions. Furthermore, our studies provide
further evidence that glia are relevant signaling partners
and not merely supporting cells for neurons, as was long
believed (Billard 2008; Halassa et al. 2007; Oliet and
Mothet 2009; Panatier et al. 2006). In fact, glia do not only
protect neurones by glutamate uptake, but our results show
Table 1 Changes in D-serine and glycine synthesis from L-serine after hypoxia, hypoglycemia and OGD
13C3 L-serine
use (lM)
13C3 D-serine
synthesis (lM)
13C2 glycine
synthesis (lM)
13C3 D-serine synthesis/
13C3 L-serine use (%)
13C2 glycine synthesis/
13C3 L-serine use (%)
NO/NG 191.3 (SD 3.8) 0.03 (SD 0.04) 34.3 (SD 1.8) 0.02 (SD 0.02) 18.0 (SD 1.0)
HO 162.8 (SD 6.7) 0.12 (SD 0.07) 45.8 (SD 4.4) 0.08 (SD 0.05, p = 0.05) 28.3 (SD 4.0, p\0.01)
HG 231.7 (SD 4.6) 0.12 (SD 0.07) 10.7 (SD 1.3) 0.05 (SD 0.03, p = 0.09) 4.6 (SD 0.6, p\0.01)
OGD 111.7 (SD 10.8) 0.04 (SD 0.06) 57.0 (SD 3.6) 0.04 (SD 0.06, p = 0.51) 51.5 (SD 7.4, p\0.01)
D-Serine and glycine synthesis from L-serine was studied by analysis of resulting
13C3 D-serine and
13C2 glycine concentrations in the medium
upon addition of
13C3 L-serine. The table depicts medium concentration changes in
13C3 L-serine (added to a medium concentration of 285 lM),
13C3 D-serine and
13C2 glycine after rat glioma C6 cells were exposed to 48 h of NO/NG, hypoxia (HO), hypoglycemia (HG) or OGD (n = 6 for
each condition). The last two columns represent the percentage of
13C3 D-serine and
13C2 glycine synthesis, respectively, of total
13C3 L-serine use
and the p value (Student’s t test) after comparison with the NO/NG condition (N = 6 for all conditions)
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123that glia also contribute to neurotoxicity by increasing
extracellular D-serine and glycine concentrations.
Both D-serine and glycine concentrations appear to rise
through increased synthesis from L-serine. A central role
for D-serine synthesis from L-serine by SR during OGD is
evidenced by SR knock-out mice, displaying 90% reduced
D-serine concentrations and decreased neurotoxicity and
dramatically diminished infarct volume after middle cere-
bral artery occlusion (Mustafa et al. 2010). For glycine, we
showed in our isotope studies that glycine synthesis from
L-serine almost tripled from 18% under control conditions
to 51.5% after OGD. Since use of labeled L-serine
decreased after OGD, this might represent a speciﬁc shift
of L-serine use towards glycine synthesis. However, the
concentration differences might also in part be explained
by ischemia-induced changes in re-uptake pumps, as have
been described for glutamate (Huang et al. 1993). This was
not speciﬁcally assessed in our study and would be inter-
esting to investigate in future experiments.
The relative contribution of D-serine and glycine to
NMDAr-induced neuronal death following ischemia
remains unclear. Addition of D-amino acid oxidase (DAO),
the enzyme that degrades D-serine and not glycine, led to
diminished cell death upon application of NMDA or OGD
(Katsuki et al. 2004). Similarly, NMDA-elicited neuro-
toxicity in rat hippocampal slices was virtually abolished
by complete removal of D-serine (Shleper et al. 2005). The
effects of endogenous glycine could be observed only after
simultaneous removal of endogenous D-serine and block-
age of the glycine transporter GlyT1. Thus, although levels
of glycine were tenfold higher than D-serine in this study,
endogenous D-serine might be the dominant co-agonist for
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123NMDA-elicited neurotoxicity (Shleper et al. 2005). This
important role of D-serine in neurotoxicity following
ischemia is conﬁrmed by the dramatically diminished
neurotoxicity and infarct volume in SR knock-out mice
(Mustafa et al. 2010). Moreover, simultaneous elevation of
both NMDAr co-agonists as seen in our experiments, in
combination with the known increases in extracellular
glutamate concentrations (Benveniste et al. 1984; Gucuy-
ener et al. 1999; Puka-Sundvall et al. 1996; Ueda et al.
1992) must lead to NMDAr-associated excitotoxicity.
During the reperfusion phase, we observed increased but
normalizing glycine concentrations in vitro and in vivo.
This concurs with the few reports describing increased
glycine concentrations in mammalian CSF or microdialy-
sates after global ischemia (Baker et al. 1991; Phillis and
Walter 1989; Roldan et al. 1999). Interestingly, we
observed signiﬁcantly reduced D-serine concentrations
during the reperfusion phase, both in vitro and in vivo. This
concurs with the ﬁnding of delayed transient decreases of
SR (mRNA and protein) and D-serine in the ipsilateral
temporoparietal mouse cortex after permanent focal
ischemia (Wang and Zhu 2004). In accordance with the
model of a safety mechanism, this reduction in D-serine
concentrations during reperfusion might represent an
attempt to compensate for increased NMDAr activity.
Potentially, the elevated glycine concentrations contribute
to this phenomenon, since glycine inhibits SR activity at
these concentrations (Strisovsky et al. 2005).
This pattern of concentration changes induced by
hypoxia–ischemia and reperfusion was consistent with the
analyses performed in CSF withdrawn from human new-
borns with and without perinatal asphyxia 24–48 h after
birth, thus representing the reperfusion phase (Table 2).
Asphyxiated neonates displayed higher glycine concentra-
tions and percentage glycine of the sum of L-serine and
glycine (an indication for the amount of glycine synthesis
from L-serine) and in the most serious case of asphyxia also
lower D-serine concentrations and percentage D-serine of the
sum of D- and L-serine (an indication for the quantity of
D-serine synthesis from L-serine) than controls. The ﬁnding
of alterations in the CSF, which represents just a global
markerforchangesintheCNS,emphasizesthemagnitudeof
concentrationchangesoftheNMDArco-agonistsinspeciﬁc
brain areas.
In conclusion, our results encourage the development of
effective and safe drugs preventing NMDAr overactivation
after global ischemia. Therapeutic agents for hypoxia–
ischemia, including competitive and non-competitive
NMDAr inhibitors, as well as NR1 antagonists have been
largely disappointing (Madden 2002; Warach et al. 2006),
partly due to signiﬁcant side effects (Groenendaal et al.
2002; Levene et al. 1995). New strategies, such as manipu-
lating co-agonist concentrations by inﬂuencing enzyme
kineticsmightformamoresubtlealternative.Theprotective
effect of hypothermia, a currently promising method to
decrease neuronal damage in asphyxiated infants with
severe encephalopathy, might at least in part rely on reduc-
ing glutamate (Baker et al. 1991; Illievich et al. 1994) and
glycine (Baker et al. 1991; Simpson et al. 1991) concentra-
tions, as observed in rabbit hippocampus microdialysates
and in superfusates from rat cerebral cortical slices.
Although D-serine concentrations have not yet been inves-
tigated in hypothermia, these results show that the reduction
of the concentrations of the NMDAr (co)-agonists might be
beneﬁcial in global ischemia. Targeting the glycine and
particularly the D-serine synthetic pathway may provide an
attractive novel treatment option for asphyxiated neonates.
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